Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

CTNMCTNM
5 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in CONTINEUM THERAPEUTICS INC

Qube Research & Technologies Ltd holds 182,413 shares of CTNM (CONTINEUM THERAPEUTICS INC), worth $3M as of 2026-Q2. The position was decreased (-21.6% shares). CTNM represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$3M

Current Shares

182,413

Total Value Change

+$2.9M

Total Shares Change

+171,489

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
182,413
-21.6%
$3M0.0%$16.39
0
2026-Q1
Increased
232,534
+439.8%
$3M0.0%$14.10
43
2025-Q4
New
43,078
-
$492,3820.0%$11.40
33
2025-Q3
Exited
0
-100.0%
$00.0%$11.82
0
2025-Q2
New
10,924
-
$43,3680.0%$4.11
31

Other major holders of CTNM: Janus Henderson Group Ltd., BlackRock, Inc., FRANKLIN RESOURCES INC, BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used